von Willebrand Disease, Type 2N
|
0.500 |
Biomarker
|
disease |
BEFREE |
Type 2N von Willebrand disease (VWD) is characterized by impaired factor VIII (FVIII) binding to von Willebrand factor (VWF).
|
31741138 |
2020 |
von Willebrand Disease, Type 2N
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
In particular, non-random occurrence was revealed for SERPINA1 c.1096G > A (alpha-1 antitrypsin deficiency), C8B c.1282C > T and c.1653G > A (complement component 8B deficiency), ATP7B c.3207C > A (Wilson disease), PROP1 c.301_302delAG (combined pituitary hormone deficiency), CYP21A2 c.844G > T (non-classical form of adrenogenital syndrome), EYS c.1155T > A (retinitis pigmentosa), HADHA c.1528G > C (LCHAD deficiency), SCO2 c.418G > A (cytochrome c oxidase deficiency), OTOA c.2359G > T (sensorineural deafness), C2 c.839_866del (complement component 2 deficiency), ACADVL c.848T > C (VLCAD deficiency), TGM5 c.337G > T (acral peeling skin syndrome) and VWF c.2561 G > A (von Willebrand disease, type 2N).
|
31028847 |
2019 |
von Willebrand Disease, Type 2N
|
0.500 |
Biomarker
|
disease |
BEFREE |
Accordingly, we always recommend VWF:FVIIIB assay in the diagnostic workup of VWD.
|
29115006 |
2018 |
von Willebrand Disease, Type 2N
|
0.500 |
Biomarker
|
disease |
BEFREE |
The impaired capacity of von Willebrand factor to carry factor VIII is identified as type 2N von Willebrand's disease.
|
22875612 |
2013 |
von Willebrand Disease, Type 2N
|
0.500 |
Biomarker
|
disease |
BEFREE |
We evaluated the first commercial ELISA (Asserachrom® VWF:FVIIIB; Stago) comparated to a reference method in a multicentric study involving 205 subjects: 60 healthy volunteers, 37 haemophiliacs A, 17 haemophilia A carriers, 37 patients with type 2N VWD, 9 heterozygous carriers for a 2N mutation and 45 patients with miscellaneous other types of VWD (all previously characterized).
|
21371195 |
2011 |
von Willebrand Disease, Type 2N
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Our aim was to assess the utility of the in-house VWF-FVIII binding assay in the investigation of patients with suspected VWD2N.
|
19298374 |
2009 |
von Willebrand Disease, Type 2N
|
0.500 |
Biomarker
|
disease |
BEFREE |
The defective FVIII carrier function of von Willebrand factor (VWF) identifies type 2N von Willebrand disease (VWD), a variant with a pattern resembling hemophilia A.
|
17456630 |
2007 |
von Willebrand Disease, Type 2N
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We conclude that R763G is a new type 2N VWD mutation located in the VWF propeptide which alters the proteolytic processing of VWF and consequently its binding to FVIII.
|
16953269 |
2006 |
von Willebrand Disease, Type 2N
|
0.500 |
Biomarker
|
disease |
BEFREE |
Type 2N von Willebrand disease (VWD) is characterized by a markedly decreased affinity of von Willebrand factor (VWF) for factor VIII (FVIII).
|
15461624 |
2004 |
von Willebrand Disease, Type 2N
|
0.500 |
Biomarker
|
disease |
BEFREE |
In type 2N von Willebrand disease (VWD), von Willebrand factor (VWF) is characterized by a markedly decreased affinity for Factor VIII (FVIII), and the mutations responsible are essentially located in the D' domain of VWF.
|
12588349 |
2003 |
von Willebrand Disease, Type 2N
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Most of them induce a classical type 2N von Willebrand disease phenotype with factor VIII deficiency but a normal level and multimeric pattern of von Willebrand factor.
|
11686103 |
2001 |
von Willebrand Disease, Type 2N
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
The majority of patients with type 2N von Willebrand disease (VWD type 2N) have mutations in the region of the von Willebrand factor (VWF) gene encoding the factor VIII binding domain of VWF.
|
9684781 |
1998 |
von Willebrand Disease, Type 2N
|
0.500 |
Biomarker
|
disease |
BEFREE |
In this report, we describe the case of a vWD patient who has an abnormal vWF multimers distribution associated with a markedly decreased vWF ability to bind FVIII.
|
9845532 |
1998 |
von Willebrand Disease, Type 2N
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Type 2N von Willebrand disease due to Arg91Gln substitution and a cytosine deletion in exon 18 of the von Willebrand factor gene.
|
9792286 |
1998 |
von Willebrand Disease, Type 2N
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Changes in factor VIII binding capacity of von Willebrand factor and factor VIII coagulant activity in two patients with type 2N von Willebrand disease after hemostatic treatment and during pregnancy.
|
8854570 |
1996 |
von Willebrand Disease, Type 2N
|
0.500 |
Biomarker
|
disease |
BEFREE |
A screening program for the detection of patients with von Willebrand disease type 2N (VWD 2N) was carried out in 177 unrelated patients previously diagnosed with haemophilia A and in 199 unrelated patients with VWD type 1 in comparison.
|
8903002 |
1996 |
von Willebrand Disease, Type 2N
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Type 2N von Willebrand disease (vWD) is caused by a mutation in the vWF gene that results in vWF with a normal multimeric pattern, but with reduced binding to FVIII.
|
8822593 |
1996 |
von Willebrand Disease, Type 2N
|
0.500 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
von Willebrand Disease, Type 2N
|
0.500 |
Biomarker
|
disease |
CTD_human |
|
|
|